Drug Metabolism and Disposition : Impact Factor & More
eISSN: 1521-009XpISSN: 0090-9556
Share this on:
Aims and Scope of Drug Metabolism and Disposition
Drug Metabolism and Disposition is a peer-reviewed scientific journal covering the fields of pharmacology and toxicology. It was established in 1973 and is published monthly by the American Society for Pharmacology and Experimental Therapeutics. The journal publishes articles on in vitro and in vivo studies of the metabolism, transport, and disposition of drugs and environmental chemicals, including the expression of drug-metabolizing enzymes and their regulation. As of 2011, the editor-in-chief is Edward T. Morgan (Emory University). Less
Key Metrics
CiteScore 
7
Eigenfactor
0.005 - 0.01
H-Index
189
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
1.13
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Drug Metabolism and Disposition
Drug Metabolism and Disposition Journal Specifications
| Overview | |
| Publisher | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1973 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drug Metabolism and Disposition ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drug Metabolism and Disposition
Erratum to "A semimechanistic PK/PD model-informed Taxus tablets' development: Accelerating early clinical translation of a taxane-based antitumor agent" [Drug Metabolism and Disposition 54 (2026) 100262
- 12 May 2026
- Drug metabolism and disposition: the biological fate of chemicals
Reduction in estimated glomerular filtration rate observed with doravirine is caused by inhibition of organic cation transporter 2.
- 5 May 2026
- Drug metabolism and disposition: the biological fate of chemicals
Gut microbial resistance and metabolism of selective serotonin reuptake inhibitors drive multidrug resistance and contribute to antidepressant tachyphylaxis.
- 1 May 2026
- Drug metabolism and disposition: the biological fate of chemicals
Ketone reduction drives major circulating metabolites of GDC-8264 in humans.
- 1 May 2026
- Drug metabolism and disposition: the biological fate of chemicals
Identification of ADH isoforms catalyzing hydroxyzine oxidation using recombinant human ADH: Serendipitous finding of potent ADH inhibition by organic solvents
- 1 May 2026
- Drug Metabolism and Disposition
Molnupiravir is not a selective CES2 probe substrate: in vitro evidence for CES1 involvement.
- 1 May 2026
- Drug metabolism and disposition: the biological fate of chemicals
Erratum to "A semimechanistic PK/PD model-informed Taxus tablets' development: Accelerating early clinical translation of a taxane-based antitumor agent" [Drug Metabolism and Disposition 54 (2026) 100262
- 12 May 2026
- Drug metabolism and disposition: the biological fate of chemicals
Reduction in estimated glomerular filtration rate observed with doravirine is caused by inhibition of organic cation transporter 2.
- 5 May 2026
- Drug metabolism and disposition: the biological fate of chemicals
Gut microbial resistance and metabolism of selective serotonin reuptake inhibitors drive multidrug resistance and contribute to antidepressant tachyphylaxis.
- 1 May 2026
- Drug metabolism and disposition: the biological fate of chemicals
Ketone reduction drives major circulating metabolites of GDC-8264 in humans.
- 1 May 2026
- Drug metabolism and disposition: the biological fate of chemicals
Identification of ADH isoforms catalyzing hydroxyzine oxidation using recombinant human ADH: Serendipitous finding of potent ADH inhibition by organic solvents
- 1 May 2026
- Drug Metabolism and Disposition
Molnupiravir is not a selective CES2 probe substrate: in vitro evidence for CES1 involvement.
- 1 May 2026
- Drug metabolism and disposition: the biological fate of chemicals
FAQs on Drug Metabolism and Disposition
How long has Drug Metabolism and Disposition been actively publishing? 
What is the publishing frequency of Drug Metabolism and Disposition?
How many articles did Drug Metabolism and Disposition publish last year?
What is the eISSN & pISSN for Drug Metabolism and Disposition?
What is Citescore for Drug Metabolism and Disposition?
What is the H Index for Drug Metabolism and Disposition ?
What is SNIP score for Drug Metabolism and Disposition?
What is the SJR for Drug Metabolism and Disposition?
Who is the publisher of Drug Metabolism and Disposition?
